Waltham COVID-19 Info

Click on the icons below for more info on the following:

v  t  d  announcements  resources

Current Policies & Advisories in Waltham

None at this time. See the full outline/requirements from Mass.gov here

Vaccination Information

As of now, everyone age 6 months and older who lives, works, or studies in MA is now eligible for the COVID-19 vaccine! The COVID-19 Vaccine is free and one of the best ways to protect yourself and those around you from getting sick from COVID-19. 

COVID-19 Testing

Testing is available to all MA residents - Testing is not restricted to residents of the cities where sites are located.

Data Dashboard 

As of 10/21/2022, the COVID-19 Dashboards will no longer be updated on this website. For information about COVID-19 in Massachusetts, CDC COVID-19 Community Levels, and Massachusetts COVID-19 vaccination rates please refer to the following links:

Current News / Announcements

*Sign up for CODE-RED citywide urgent alerts  // Subscribe to City news & announcements

  • 10/19/22: The CDC approved the Novavax monovalent booster for individuals ages 18 and older who have completed primary series vaccination but have not previously received a COVID-19 booster as an alternative to the bivalent mRNA boosters (Pfizer or Moderna) for individuals who are unable to receive an mRNA vaccine, a lack of availability of an mRNA vaccine or for those who are unwilling to receive mRNA vaccines and who would otherwise not receive a booster dose.  
  • 10/12/22: The bivalent COVID-19 booster has received CDC and FDA approval for children ages 5 through 17 years. The Pfizer-BioNTech bivalent COVID-19 booster is authorized for children ages 5 through 11 years, while the Moderna bivalent booster is approved for children and adolescents ages 6 through 17 years. 
  • 8/31/22: The FDA authorized emergency use of the Moderna and Pfizer-BioNTech bivalent COVID-19 boosters as a single dose at least two months following primary or booster vaccination. The updated boosters provide protection against the original strain of COVID-19 and the omicron variant.  
  • 8/22/22: The CDC announced their recommendation of the Novavax COVID-19 vaccine for individuals aged 12 through 17 following the FDA's approval for emergency use. The Novavax vaccine is now approved under emergency use authorization (EUA) for individuals 12 and older. 
  • 8/15/22: The Massachusetts Department of Public Health (MDPH) updates the COVID-19 Isolation and Quarantine guidance for the general public following updated guidance from the CDC.